Han Biomedical (ROCO:6999) FCF Margin %: 13.63% (As of Dec. 2025) — 48% Below Median


ROCO:6999 Han Biomedical Inc ROCO:6999
25 GF Score
Price NT$30.00
! 1 Warning Sign
View Full Analysis

What is Han Biomedical FCF Margin %?

Han Biomedical ROCO:6999 +0.17% 25 FCF Margin % is 13.63% as of Dec. 2025, which is 48% below its 10-year median of 26.39. GuruFocus rates ROCO:6999 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 949 Biotechnology companies, Han Biomedical ranks better than 67.44% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Han Biomedical's Free Cash Flow for the six months ended in Dec. 2025 was NT$8.9 Mil. Han Biomedical's Revenue for the six months ended in Dec. 2025 was NT$65.4 Mil. Therefore, Han Biomedical's FCF Margin % for the quarter that ended in Dec. 2025 was 13.63%.

As of today, Han Biomedical's current FCF Yield % is -2.12%.

The historical rank and industry rank for Han Biomedical's FCF Margin % or its related term are showing as below:

ROCO:6999' s FCF Margin % Range Over the Past 10 Years
Min: -11.08   Med: 26.39   Max: 38.41
Current: -11.08

During the past 5 years, the highest FCF Margin % of Han Biomedical was 38.41%. The lowest was -11.08%. And the median was 26.39%.

ROCO:6999's FCF Margin % is ranked better than
67.44% of 949 companies
in the Biotechnology industry
Industry Median: -82.65 vs ROCO:6999: -11.08

Han Biomedical FCF Margin % Related Terms

Han Biomedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Han Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical FCF Margin % Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
38.41 24.50 31.81 26.39 -11.08

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial 14.56 25.66 27.00 -37.66 13.63

ROCO:6999 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Han Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Han Biomedical FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Han Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Han Biomedical's FCF Margin % falls into.


ROCO:6999
25GF Score
Han Biomedical Inc ROCO:6999
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Han Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Han Biomedical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.988/126.209
=-11.08 %

Han Biomedical's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=8.913/65.393
=13.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 13.63% mean?
Han Biomedical (ROCO:6999) has a FCF Margin % of 13.63% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Han Biomedical and its competitors. This is 48% below median its historical median of 26.39. According to the industry distribution chart, Han Biomedical ranks #309 out of 949 companies in the Biotechnology industry, placing it in the top 32.6%.
Is Han Biomedical's FCF Margin % too high?
Han Biomedical's current FCF Margin % of 13.63% is 48% below median its 10-year median of 26.39. Based on the distribution chart, Han Biomedical ranks #309 out of 949 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Han Biomedical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #309 out of 949 companies for FCF Margin %. This puts Han Biomedical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Han Biomedical and its competitors. Han Biomedical's current FCF Margin % is 13.63%, which is 48% below median its own 10-year median of 26.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current FCF Margin % of 13.63%. The current FCF Margin % is 13.63%, which is 48% below median its 10-year median of 26.39. Han Biomedical's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current FCF Margin % is 13.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
25GF Score

Get the complete analysis for ROCO:6999

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.00
Price